Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 233
Ph III recruiting: 18
Growth YoY: +3.1%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 51–90 of 90 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02787915	DC1s-CTL Cellular Therapy for Renal Cell Carcinoma	unknown	Phase 1 / Phase 2	50	Xuzhou Medical UniversityOTHER	0	Jun 2, 2016	clinicaltrials
NCT02774200	A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.	unknown	Phase 2	20	Tianjin Medical University Cancer Institute and HospitalOTHER	0	May 17, 2016	clinicaltrials